1700693-96-4

1700693-96-4 structure
1700693-96-4 structure
  • Name: ARN5187 trihydrochloride
  • Chemical Name: 4-({[1-(2-Fluorophenyl)cyclopentyl]amino}methyl)-2-[(4-methyl-1-piperazinyl)methyl]phenol trihydrochloride
  • CAS Number: 1700693-96-4
  • Molecular Formula: C24H35Cl3FN3O
  • Molecular Weight: 506.91
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2018-07-07 14:02:03
  • Modify Date: 2024-01-16 08:38:40
  • ARN5187 trihydrochloride is a lysosomotropic REV-ERBβ ligand with a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy. ARN5187 trihydrochloride shows lysosomotropic potency and cytotoxicity. ARN5187 trihydrochloride induces apoptosis[1][2].

Name 4-({[1-(2-Fluorophenyl)cyclopentyl]amino}methyl)-2-[(4-methyl-1-piperazinyl)methyl]phenol trihydrochloride
Synonyms 4-({[1-(2-Fluorophenyl)cyclopentyl]amino}methyl)-2-[(4-methyl-1-piperazinyl)methyl]phenol trihydrochloride
Phenol, 4-[[[1-(2-fluorophenyl)cyclopentyl]amino]methyl]-2-[(4-methyl-1-piperazinyl)methyl]-, hydrochloride (1:3)
Description ARN5187 trihydrochloride is a lysosomotropic REV-ERBβ ligand with a dual inhibitory activity toward REV-ERB-mediated transcriptional regulation and autophagy. ARN5187 trihydrochloride shows lysosomotropic potency and cytotoxicity. ARN5187 trihydrochloride induces apoptosis[1][2].
Related Catalog
Target

REV-ERBβ[1]

In Vitro ARN5187 trihydrochloride (compound 1) (0-100 µM; 48 h) shows cytotoxicity with EC50 of 23.5 µM in BT-474 cells and IC50 of 30.14 µM, >100 µM for BT-474 and HMEC cells, respectively[1][2]. ARN5187 trihydrochloride (0-100 µM) activates the RevRE reporter in a concentration-dependent manner in HEK-293 cells[1]. ARN5187 trihydrochloride (25, 50 µM) is a lysosomotropic-independent REV-ERB antagonistic activity[1]. ARN5187 trihydrochloride (50 µM; 24 h) shows autophagy inhibition[1]. ARN5187 trihydrochloride (50 µM; 2, 8, 24 h) effects autophagy formation and maturation[1]. Cell Cytotoxicity Assay[1] Cell Line: BT-474 cells Concentration: 0-100 µM Incubation Time: 48 h Result: Showed cytotoxicity with EC50 of 23.5 µM. Western Blot Analysis[1] Cell Line: BT-474 cells Concentration: 50 µM Incubation Time: 24 h Result: Significantly increased the expression of α-LC3-II, α-p62, α-Cleaved PARP. RT-PCR[1] Cell Line: BT-474 cells Concentration: 25, 50 µM Incubation Time: Result: Significantly enhanced the expression of BMAL1, PER1 and PEPCK in a dose-dependent manner.
References

[1]. De Mei C, et al. Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells. Oncogene. 2015 May 14;34(20):2597-608.

[2]. Torrente E, et al. Synthesis and in Vitro Anticancer Activity of the First Class of Dual Inhibitors of REV-ERBβ and Autophagy. J Med Chem. 2015 Aug 13;58(15):5900-15.

Molecular Formula C24H35Cl3FN3O
Molecular Weight 506.91
Exact Mass 505.182983
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.